Pubblicazioni

HDAC inhibition by valproic acid decreases JAK2V617F levels in myeloproliferative neoplasms via up-regulation of miR-101, in vivo and in vitro

2018 - HEMASPHERE
De Marinis, E.; Cenfra, N.; Liberati, D.; Scerpa, M. C.; Pagano, F.; Quattrocchi, A.; Tomassini, S.; Gentile, M.; Ceccherelli, A.; Cicalini, A.; Fantasia, F.; Cimino, G.; Nervi, C.

A novel germline CALR mutation affecting an evolutionary conserved region of 3’UTR in JAK2-negative siblings with Polycythemia Vera

2018 - HEMASPHERE
Quattrocchi, A.; Tomassini, S.; Scerpa, M. C.; Cenfra, N.; Pisanò, S.; De Marinis, E.; Gentile, M.; Ceccherelli, A.; Maiorca, C.; Cicalini, A.; Fantasia, F.; Cimino, G.; Nervi, C.

Hepatitis C virus infection-associated macrophage activation syndrome in a pediatric patient which underwent hematopoietic stem cell transplantation for acute lymphoblastic leukemia

2018 - HEMASPHERE
Laccetta, Gianluigi; Menconi, Mariacristina; Bernasconi, Sayla; Casazza, Gabriella; Brunetto, Marzia

Combination targeting of sialylation and the proteasome inhibits tumor growth and increases survival in a humanized mouse multiple myeloma model

2018 - HEMASPHERE
Reagan, M.; Farrell, M.; Macauley, M.; Natoni, A.; Fairfield, H.; O’Dwyer, M.

Targeting siglec-7: a novel immunotherapeutic approach to potentiate the cytotoxic functions of natural killer cells against multiple myeloma

2018 - HEMASPHERE
Daly, J.; Sarkar, S.; Natoni, A.; Hu, J.; Chauhan, S.; Henderson, R.; Duggan, T.; Kirkham, L.; Mcellistrim, C.; O’Dwyer, M.

Novel kinase inhibitors afuresertib and pim447 are active in a predictive myeloma in vivo model, and a crispr genome-wide screening approach identifies biomarkers determining susceptibility

2018 - HEMASPHERE
Keane, N.; Sharik, M.; Natoni, A.; Chesi, M.; Bergsagel, L.; Michael, O.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma